Muscle Stimulation Devices Market Size, Share, Growth & Forecasts 2024-2032

Comments · 39 Views

The global muscle stimulation devices market size was worth around USD 780.5 million in 2022 and is predicted to grow to around USD 1002.5 million by 2030 with a compound annual growth rate (CAGR) of roughly 3.18% between 2023 and 2030.

The global muscle stimulation devices market size was worth around USD 780.5 million in 2022 and is predicted to grow to around USD 1002.5 million by 2030 with a compound annual growth rate (CAGR) of roughly 3.18% between 2023 and 2030.

Market expansion is anticipated to be further propelled by the increased prevalence of musculoskeletal disorders among the general populace and the emphasis on pain management remedies within the field of sports medicine.

Muscle Stimulation Devices Market

Muscle stimulators serve a multitude of functions within the field of physical therapy. The primary functions of muscle stimulators are to augment muscle strength, tone muscles, and improve blood circulation. This is accomplished by inducing muscle contraction within the body via the introduction of electrical currents. Electrical apparatus uses a series of electrodes, which are frequently adhesive pads, to deliver current to a particular area of the body. Muscles are contracted by electronic muscle stimulators, which transmit electrical signals.

The global market for muscle stimulators is expanding steadily due to a number of significant factors. One notable aspect is the increasing prevalence of muscle stimulators within the physiotherapy profession, which can be attributed to their efficacy in facilitating rehabilitation and augmenting muscular strength.

Innovative products have been developed as a result of technological advances in medical devices, including wearable muscle stimulator devices that provide users with increased flexibility and convenience. An increasing focus on pain management therapies within the field of sports medicine has contributed to the burgeoning need for muscle stimulators. This is because athletes strive to enhance their performance and recuperate from injuries with greater efficacy.

Musculoskeletal disorders are a substantial catalyst for market expansion, as evidenced by the noteworthy rise in their worldwide incidence. These disorders are frequently ascribed to elements including sedentary lifestyles, poor body posture, and unwholesome dietary practices.

Consequently, a heightened consciousness has emerged regarding the significance of proactive measures in musculoskeletal health management, which has propelled the integration of muscle stimulators into both preventative and therapeutic approaches. Back discomfort, specifically, arises as a widespread concern, impacting a significant proportion of the global population and resulting in substantial disability.

Constraints regarding usability and functionality are being altered as a result of developments in muscle stimulator design and functionality. An example of this is the implementation of wearable muscle stimulator devices, like the Neuro20 PRO System, which represents a transition towards more all-encompassing approaches that accommodate the varied requirements of users.

These devices utilise sophisticated technologies in order to deliver precise stimulation to particular muscle groups, thereby providing increased adaptability and personalised possibilities. Furthermore, the incorporation of portable and wireless functionalities, in conjunction with smartphone compatibility, amplifies the ease of use and accessibility of muscle stimulators, thereby creating novel avenues for expansion for industry participants.

Additionally, musculoskeletal disorders are caused by factors such as improper diets and lack of physical activity among the populace, which contributes to the expansion of the market. Due to the heightened vulnerability of the geriatric population and the exponential growth of their population, the prevalence of these disorders escalates.

As illustrated by the United Nations World Population Prospects 2022, the proportion of the world's population comprising individuals aged 65 years or older is anticipated to increase from 10 percent in 2022 to 16 percent by 2050. Additionally, the source predicted that by 2050, the global population of individuals aged 65 or older would surpass that of children under the age of five by more than two-fold, and be roughly equivalent to the population of children under the age of twelve.

The increased susceptibility of the elderly to neuromuscular diseases is anticipated to generate a demand for muscle stimulator devices for therapeutic purposes, consequently propelling the expansion of the market.

Furthermore, a study published in June 2022 in the Journal of Family Medicine and Primary Care reveals that musculoskeletal disorders affect 1,194 cases per 100,000 children aged 5 to 19 years in India annually. Thus, it is anticipated that the high prevalence of musculoskeletal disorders among minors in India will stimulate the treatment market for muscle stimulators, thereby driving the expansion of the market under study.

Moreover, the introduction of numerous technologically advanced products is contributing to the expansion of the market. As an illustration, CUTERA, INC. declared the introduction of the subsequent iteration of truSculpt flex in December 2021. Enhancing Cutera's proprietary Multi-Directional Stimulation, the new truSculpt flex+ rapid treatment mode delivers identical toning, firming, and strengthening outcomes in a significantly reduced treatment duration.

Muscle Stimulation Devices Market

Thus, the market is anticipated to expand due to the aforementioned factors—increasing product introductions, the geriatric population, and the increasing prevalence of neuromuscular disorders. However, market expansion is anticipated to be impeded by the existence of effective alternative therapies, stringent regulatory policies, and safety concerns.

Global Muscle Stimulation Devices Market: Competitive Players

The global muscle stimulation devices market is led by players like :

  • DJO Global Inc
  • Axiobionics
  • R.S. Medical Inc
  • Neurometrix Inc
  • Omron Corporation

The global muscle stimulation devices market is segmented as follows:

By Product Type

  • TENS or Transcutaneous Electric Nerve Stimulator
  • NMES or Neuromuscular Electric Stimulation
  • BMAC or Burst Mode Alternating Current

By Application

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers

By End User

  • Pain Management
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Others

Global Muscle Stimulation Devices Market: Regional Segment Analysis

  • North America The U.S.
  • Europe The UK France Germany
  • The Asia Pacific China Japan India
  • Latin America Brazil
  • The Middle East and Africa

Analysis of the Muscle Stimulation Devices Market

The segment dedicated to transcutaneous electrical nerve stimulators (TENS) is anticipated to experience significant growth by 2032, propelled by the rising incidence of chronic pain and muscle-related sports injuries. Numerous device manufacturers are developing cutting-edge transcutaneous electrical nerve stimulators that feature technologies that are likely to promote their widespread use.

By 2032, the pain management market is anticipated to generate substantial revenue. The prevalence of chronic pain has led to an increase in the utilisation of muscle stimulation devices for the purpose of pain management. These devices, renowned for their capacity to mitigate pain and facilitate rehabilitation, demonstrate efficacy in the management of a wide range of pain conditions, encompassing both acute and chronic scenarios. Muscle stimulation devices are an appealing option for healthcare professionals and patients equally who are looking for non-invasive and drug-free alternatives to pain medication due to their versatility and effectiveness.

The market for muscle stimulation devices in Europe is anticipated to grow at a significant CAGR through 2032. The proliferation of chronic pain, muscle injuries, and various other maladies in the area has significantly contributed to the advancement of muscle stimulation devices.

Based on reliable sources, the prevalence of chronic pain in Europe is estimated to impact approximately 100 million individuals, or one in every five adults. Furthermore, the burgeoning elderly demographic in Europe, characterised by a heightened vulnerability to chronic pain, presents profitable prospects for industry participants operating in the area.

Muscle Stimulation Devices Market Share

The list of leading muscle stimulation devices industry players includes:

  • DJO Global Inc. (Colfax Corporation)
  • Omron Corporation
  • Neuro Metrix Inc
  • Axiobionics

 

The effects of the Russia-Ukraine conflict on the muscle stimulation device market

Repercussions of the Russia-Ukraine conflict on the healthcare industry included disruptions in the supply of basic materials. Both countries possess vital basic materials that are utilised in the production of diagnostic devices. Nonetheless, deteriorating geopolitical tensions impeded the development of vital trade routes and impeded industry progress. Notwithstanding these challenges, governments worldwide are collectively endeavouring to resolve the conflict, a development that is anticipated to stimulate the economy and facilitate a degree of recuperation in the sector.

Contact Us:

Zion Market Research

USA/Canada Toll Free: 1 (855) 465-4651

Newark: 1 (302) 444-0166

Web: https://www.zionmarketresearch.com/

Blog: https://zmrblog.com/

Comments